DuPont de Nemours, Inc. DD
156.88 USD +1.74 (+1.12%)
At closeNov 11, 2026, 8:08 AM EST
158.02 +1.14 +0.73%
Pre-market · Nov 11, 8:08 AM ET
153.37 Day range 157.05
111.15 52-week range 157.98
- YTD
- +30.08%
- 1 year
- +29.95%
Benzinga news
benzinga.com Jim Cramer Picks DuPont Over Xylem, Has Cold Feet on Lam Research Xylem, a water technology provider, saw its shares fall 1% to close at $100.05 on Thursday. Vertiv shares dipped 14% to settle at $176.73.
benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Raises Price Target to $173 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and raises the price target from $160 to $173.
benzinga.com Wells Fargo Maintains Overweight on DuPont de Nemours, Raises Price Target to $170 Wells Fargo analyst Abigail Eberts maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $166 to $170.
benzinga.com UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $182 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $172 to $182.
benzinga.com Citigroup Maintains Buy on DuPont de Nemours, Raises Price Target to $176 Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $162 to $176.- benzinga.com Barclays Maintains Overweight on DuPont de Nemours, Raises Price Target to $176 Barclays analyst Aleksey Yefremov maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $156 to $176.
- benzinga.com Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Fermium Research analyst Frank Mitsch maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $154 to $160.
benzinga.com Fabrinet, EverQuote, Lattice Semiconductor, Fiserv And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed as Dow fell 200 points; Fabrinet surged 13.7% on strong results, guidance and buyback, while several small caps rallied.
benzinga.com DuPont Raises Outlook As Order Book Climbs and AI Cuts Development Time DuPont earnings beat estimates as double-digit orders, AI gains and stronger guidance offset Middle East water delays.
benzinga.com DuPont de Nemours Q3 2026 Earnings Call Transcript DuPont de Nemours (NYSE:DD) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com DuPont de Nemours Sees Q4 Adj EPS $1.90-$1.95 vs $1.87 Est; Sees Sales $1.825B vs $1.824B Est DuPont de Nemours (NYSE:DD) is looking for Q4 Adj EPS of $1.90-$1.95 vs $1.87 analyst estimate. sees sales of $1.825 billion vs $1.824 billion analyst estimate.
benzinga.com DuPont de Nemours Raises FY2026 Adj EPS Guidance from $7.17-$7.32 to $7.47-$7.52 vs $7.25 Est; Raises FY2026 Sales Guidance from $7.160B-$7.190B to $7.190B vs $7.169B Est DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.17-$7.32 to $7.47-$7.52 vs $7.25 analyst estimate. Raises FY2026 sales outlook from $7.160 billion-$7.190 billion to $7.190 billion…
benzinga.com DuPont de Nemours Q3 Adj. EPS $2.09 Beats $1.87 Estimate, Sales $1.868B Beat $1.843B Estimate DuPont de Nemours (NYSE:DD) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $1.87 by 11.76 percent. This is a 36.09 percent decrease over earnings of $3.27…
benzinga.com 10 Industrials Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com DuPont Rolls Out DuPont AmberChrom SIL Silica Gel DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide…
- benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Lowers Price Target to $160 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and lowers the price target from $176 to $160.
- benzinga.com Barclays Initiates Coverage On DuPont de Nemours with Overweight Rating, Announces Price Target of $156 Barclays analyst Aleksey Yefremov initiates coverage on DuPont de Nemours (NYSE:DD) with a Overweight rating and announces Price Target of $156.
- benzinga.com JP Morgan Downgrades DuPont de Nemours to Neutral, Lowers Price Target to $145 JP Morgan analyst Chigusa Katoku downgrades DuPont de Nemours (NYSE:DD) from Overweight to Neutral and lowers the price target from $172 to $145.
- benzinga.com Citigroup Maintains Buy on DuPont de Nemours, Lowers Price Target to $162 Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $170 to $162.
benzinga.com UBS Maintains Buy on DuPont de Nemours, Lowers Price Target to $172 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $178 to $172.
benzinga.com Why Is Chemours Stock Trading Higher Today? Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing and future escrow obligations.
benzinga.com Chemours, DuPont De Nemours And Corteva Reach Settlement State Of North Carolina And 11 Local Entities; Overall Settlement Payments Total $455M Over 15 Years, With Chemours' 50% Share Of Payments Of ~$180M On NPV Basis Covered By Existing Accruals The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the- benzinga.com JP Morgan Maintains Overweight on DuPont de Nemours, Raises Price Target to $172 JP Morgan analyst Chigusa Katoku maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $171 to $172.
- benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Lowers Price Target to $176 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and lowers the price target from $180 to $176.
- benzinga.com 'California sues DuPont over alleged effort to avoid ‘forever chemicals’ liabilities'- Financial Times https://www.ft.com/content/77f00cf3-f2e6-4dcb-bf0d-1631ca45dd9c?syn-25a6b1a6=1&_gl=1*1lkg4gt*_up*MQ..&gclid=4b5f5274ad6f1d1dc16438006235df49&gclsrc=3p.ds
- benzinga.com UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $178 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $175 to $178.
benzinga.com DuPont Says It Is Exploring M&A Opportunities in Water and Healthcare DuPont Earnings Outlook improves after a Q2 beat, but a narrower sales range and currency headwinds pressure shares.- benzinga.com Conference Call:
DuPont de Nemours Sees Q3 Adj EPS $1.80-$1.90 vs $1.93 Est; Sees Sales $1.835B vs $1.877B Est DuPont de Nemours (NYSE:DD) is looking for Q3 Adj EPS of $1.80-$1.90 vs $1.93 analyst estimate. sees sales of $1.835 billion vs $1.877 billion analyst estimate.
benzinga.com DuPont de Nemours Q2 2026 Earnings Call: Complete Transcript DuPont de Nemours (NYSE:DD) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide…- benzinga.com DuPont de Nemours Raises FY2026 Adj EPS Guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 Est; Narrows FY2026 Sales Guidance from $7.155B-$7.215B to $7.160B-$7.190B vs $7.164B Est DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 analyst estimate. Narrows FY2026 sales outlook from $7.155 billion-$7.215 billion to $7.160…
benzinga.com EXCLUSIVE: Alphabet’s Empire Could Be Worth More In Pieces, Jay Woods Says Spinning off business units for companies can unlock shareholder value. Market expert Jay Woods shares his favorite spinoff potential name.- benzinga.com Qnity Electronics Stock Trends After Hours: CEO Tells Jim Cramer Company 'Right At The Center' Of Materials Innovation, The 'Hidden Hero' Of AI Era Qnity Electronics shares rose 2.85% after hours as investors reacted to the CEO’s upbeat comments on AI-driven semiconductor demand.
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com What's Going On With DuPont Stock Thursday? DuPont (DD) shares slip premarket as risk appetite softens. Explore technical analysis, support levels, and the latest market outlook.
benzinga.com EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America (CORRECTED) Women remain scarce in the C‑suite, with only a fraction of large U.S. companies led by female CEOs. A leadership‑focused ETF highlights how rare top‑level gender representation still is.- benzinga.com Earnings Scheduled For February 10, 2026
benzinga.com Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps.
benzinga.com AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto…
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Qnity Electronics Will Replace Eastman Chemical In The S&P 500, And Eastman Chemical Will Replace Caleres In The S&P SmallCap 600
Effective Prior To The Opening Of Trading On Tuesday, November 4 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251027-1480741/1480741_hon-dd-5-spin.pdf
benzinga.com DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B. Deal aligns with DuPont's strategy to improve profitability and shareholders to benefit from…- benzinga.com Earnings Scheduled For August 5, 2025
- benzinga.com Earnings Scheduled For May 2, 2025
benzinga.com US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? U.S.- benzinga.com Earnings Scheduled For February 11, 2025
- benzinga.com DuPont's Strategic Split Could Unlock Value, But PFAS Risks Loom Large, Says BofA Analyst BofA Securities analyst raises DD's price target from $74 to $80, reiterating underperform rating. Split into 3 companies may increase valuations.
- benzinga.com Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
- benzinga.com Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
- benzinga.com Earnings Scheduled For February 6, 2024 Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
- benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.